Quantcast
Last updated on April 17, 2014 at 12:58 EDT

Mendor Announces Partnership with A. Menarini Diagnostics for European-wide Distribution of its All-in-one Blood Glucose Monitoring System

May 27, 2013

ESPOO, Finland, May 27, 2013 /PRNewswire/ –

Mendor, the Finnish diabetes technology company, is proud to announce its partnership
with A. Menarini Diagnostics S.r.l, one of Europe’s leading diagnostics companies in the
field of diabetes. The agreement will bring Mendor’s all-in-one blood glucose monitoring
system to nine new European markets in the first stage as a part of Menarini’s established
GlucoMen product family for glucose testing.

A. Menarini Diagnostics S.r.l was founded in 1976 and today has a European-wide
organisation with a headquarters based in Florence and a network of fourteen fully owned
affiliates. Its 2012 turnover was approximately 300 million Euro.

A. Menarini Diagnostics has more than 35 years of experience in blood glucose
monitoring sales and marketing in European markets providing Mendor with an experienced
and successful partner in its commercial expansion in the EU area. Menarini Diagnostics
are renowned for offering cutting edge, high quality products, dedicated to exceeding the
needs of healthcare professionals and to enhancing the quality of life of patients – the
same values that have driven the development of Mendor’s products. The first launches of
this BGT system are scheduled in the near future in key European markets.

Mendor’s all-in-one blood glucose monitoring system is a unique device that contains
all the necessary components for daily blood glucose measurements: a meter, 25 strips and
a lancing device in an integrated, stylish device the size of a mobile phone. It is
designed to simplify the lives of people with diabetes who need to test their blood
glucose levels regularly. The device will be launched under the name of GlucoMen READY.

Through this new partnership Mendor hopes to ensure its continued growth and expansion
within important European markets and facilitate on-going negotiations in new territories
with key companies in the global diabetes market like Menarini. The partnership
complements Mendor’s previous distribution agreements with Merck Serono Ltd. in the UK,
Mediq in the Baltics, and continues the already mutually rewarding partnership with A.
Menarini Diagnostics Nordics in Sweden.

Mendor’s CEO Kristian Ranta comments: “We are thrilled to have such a great
partnership in place with a true frontrunner in diabetes care – Menarini. We are delighted
to have such a strong partner in Europe to take our product out to key markets and feel
proud to have gained such an important partnership to reward our development efforts. We
are looking forward to building a better future for people with diabetes together with
solid partners such as Menarini.”

The General Manager of A. Menarini Diagnostics S.r.l., Dr. Crescenzio Izzo, added: “We
are satisfied to have signed this agreement with such a young and innovative company as
Mendor. This all-in-one system shall go towards completing our current Home Glucose
testing product portfolio and allow us to offer diabetic patients a meter which is not
only an attractive in design but also clinically proven, high quality and, above all,
discreet.”

About Menarini

Menarini, headquarters of the Menarini Group, was founded in Naples in 1886 and then
moved to Florence in 1915. Today it is the leading Italian pharmaceutical company in the
world, ranking 17th in Europe and 34th in the world (IMS World Review 2012). Present in
over 100 countries throughout the world, today it counts 16,640 employees and has a 2012
turnover of over EUR3 billion. Research and internationalisation represent the main areas
of strategic development for its future.

The Group has 14 manufacturing sites located in Italy and abroad where over 545
million packages/year are produced and distributed throughout five continents, thus
allowing Menarini to contribute to the health of patients all over the world with its high
quality standards.

For further information please see our website: http://www.menarini.com.

Images available on request. For more information, visit: http://www.mendor.com

Technical information:

Mendor Discreet(TM)/Glucomen READY is a CE marked IVD medical device. It is an
all-in-one type premium class portable blood glucose monitoring device. The product has a
modern design outlook, high quality features, materials and product finishing. The device
contains all required functions in one device; test strip dispensing system, lancing
device and measuring electronics. The device has been designed for people with diabetes
who need to measure their blood glucose values as a part of their treatment.

        Media Contact:
        Sanna Usva - Mgmt Assistant
        Tel: +358-9-315-77-300
        E-mail: info@mendor.com

SOURCE Mendor


Source: PR Newswire